Even as BAT expands beyond trial criteria, patients see gains in LVEF, symptoms, and more. A survival impact remains unclear.

The presentations include late-breaking clinical data, oral sessions and posters highlighting real-world outcomes, cardiac energetics, hospitalization impact, left ventricular ejection fraction (LVEF) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Baroreflex activation therapy plus optimal medical ...

SAN DIEGO, CA — In a small trial of patients with heart failure and reduced ejection fraction (HF-REF), those who were implanted with the Barostim neo (CVRx) device, which stimulates baroreceptors in ...

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation Receive the the latest news, research, and presentations from ...

TUCSON, Ariz. (KVOA) - Carondelet St. Mary's Hospital has successfully completed its first implantation of the Barostim™ Baroreflex Activation Therapy device, marking a significant advancement in the ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved revised instructions for use for a neuromodulation device for HF. The instructions now include ...

TUCSON, Ariz. (KVOA) - Carondelet St. Mary’s Hospital has achieved a milestone by completing its first procedure to implant the Barostim™ Baroreflex Activation Therapy device. This innovative heart ...

(RTTNews) - CVRx, Inc. (CVRX) Tuesday announced today that it has received the FDA approval for revised Instructions For Use or IFU for Barostim incorporating key long-term clinical data from the BeAT ...

MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc (CVRX). (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT® ...

MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative ...